T2 Biosystems

TTOO NASDAQ
1.890
+0.060
+3.28%
After Hours: 1.830 -0.06 -3.17% 16:43 06/18 EDT
Open
1.850
Prev Close
1.830
High
1.900
Low
1.791
Volume
339.67K
Avg Vol (3M)
841.93K
52 Week High
9.61
52 Week Low
1.350
% Turnover
0.76%
Market Cap
83.80M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers T2 Biosystems TTOO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.
MORE >

Recently

Name
Price
%Change